Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v7-FR Version v3-EN
Language French English
Date Updated 2018-10-17 2018-10-17
Drug Identification Number 02453819 02453819
Brand name PRALUENT PRALUENT
Common or Proper name PRALUENT Pre-filled pens, 75 mg/mL PRALUENT Pre-filled pens, 75 mg/mL
Company Name SANOFI-AVENTIS CANADA INC SANOFI-AVENTIS CANADA INC
Ingredients ALIROCUMAB ALIROCUMAB
Strength(s) 75MG 75MG
Dosage form(s) SOLUTION SOLUTION
Route of administration SUBCUTANEOUS SUBCUTANEOUS
Packaging size 2 2
ATC code C10AX C10AX
ATC description LIPID MODIFYING AGENTS, PLAIN LIPID MODIFYING AGENTS, PLAIN
Reason for shortage Other (Please describe in comments) Other (Please describe in comments)
Anticipated start date 2018-11-20 2018-11-20
Actual start date
Estimated end date 2018-12-14 2018-12-14
Actual end date 2018-10-17
Shortage status Avoided shortage Anticipated shortage
Tier 3 Status No No
Company comments Delay in production/supply Delay in production/supply
Health Canada comments